DNA Methylation and the Cancer Epigenome Biological and Translations Implications



November 26, 2012

Stephen Baylin, Deputy Director, Johns Hopkins University School of Medicine

We are in an exciting period of increased understanding of the molecular origins of epigenetic abnormalities in cancer. The resultant biological insights are increasingly important for developing strategies for “epigenetic therapies” for cancer and biomarker development.

Cancer Research

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.